molecules-logo

Journal Browser

Journal Browser

Bioactive Compounds from Natural Sources: Novel Extraction Methods, Protection and Therapeutic Potential

A Special Issue of Molecules (ISSN 1420-3049) belonging to the section "Natural Products Chemistry".

Deadline for manuscript submissions: 30 October 2026 | Viewed by 974

Editors


E-Mail Website
Guest Editor
National School of Biological Sciences, Adolfo López Mateos Professional Unit (U.P.A.L.M.), National Polytechnic Institute (IPN), San Pedro Zacatenco, Ciudad de Mexico 07738, Mexico
Interests: bioactive compounds; therapeutic potential; bioavailability
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu Esq. Manuel Stampa, Gustavo A. Madero, Ciudad de Mexico C.P. 11340, Mexico
Interests: bioactive compounds; bioavailability; nutraceuticals; therapeutic potential
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Departamento de Ingeniería Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala S/N, Unidad Santo Tomás, Ciudad de México 11340, Mexico
Interests: encapsulation; nanoencapsulation; drug discovery

Special Issue Information

Dear Colleagues,

Bioactive compounds derived from natural sources, including plants, algae, fungi, and marine organisms, represent a resource of modern therapeutic discovery and nutraceutical development. These compounds, such as polyphenols, alkaloids, terpenoids, and peptides, exhibit a broad spectrum of biological activities, including antioxidants, anti-inflammatory, antimicrobial, and anticancer properties. However, their effective utilization depends on overcoming significant challenges in efficient extraction methodologies, suitable conservation processes, stability, and bioavailability. Traditional extraction methods, often characterized by high energy consumption, prolonged processing times, and the use of hazardous solvents, are increasingly being supplanted by novel, green technologies. Techniques such as ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE), supercritical fluid extraction (SFE), and pressurized liquid extraction (PLE) offer enhanced selectivity, reduced environmental impact, and improved preservation of thermolabile constituents.

Post-extraction purification processes are necessary to remove impurities and obtain samples that are highly concentrated, stable, and with specific activity. Some purification methods are chromatographic (such as size-exclusion, ion-exchange, and affinity chromatography); high-performance liquid chromatography (HPLC); ultra-performance liquid chromatography (UPLC); thin-layer chromatography (TLC); membrane separation techniques (including ultrafiltration and nanofiltration).

Finally, the inherent instability of many bioactivities necessitates advanced protection strategies. Encapsulation methodologies, particularly nanoencapsulation using liposomes, nano-emulsions, and biopolymer matrices, have emerged as pivotal for protecting these compounds from degradation, controlling their release, and enhancing their absorption and targeted delivery. The therapeutic potential of these optimized and protected compounds is vast and rigorously investigated. Preclinical and clinical studies continue to elucidate their mechanisms of action in mitigating chronic diseases such as cardiovascular disorders, diabetes, neurodegenerative conditions, and various cancers. By synergizing innovative extraction with advanced stabilization technologies, researchers can more effectively translate the intrinsic value of natural bioactive compounds into efficacious, reliable, and sustainable therapeutic agents, bridging the gap between traditional knowledge and contemporary pharmaceutical science.

Dr. Rosalva Mora-Escobedo
Dr. Cristian Jiménez Martínez
Dr. Liliana Alamilla
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioactive compounds
  • natural products
  • green extraction
  • purification
  • separation techniques
  • encapsulation
  • nanoencapsulation
  • therapeutic potential
  • drug discovery
  • nutraceuticals
  • stability
  • bioavailability

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 2725 KB  
Article
TRPV1 Activation Is Associated with Improved Mitochondrial Function and Cardioprotection in Experimental Hypertension
by Angélica Ruiz-Ramírez, Francisco Correa-Segura, Leonardo Del Valle-Mondragón, Arantxa Marianne Márquez-Ramírez, Israel Pérez-Torres, Oralia Medina Rodríguez, Rodrigo Velázquez-Espejel, Alvaro Vargas-González, Luz Ibarra-Lara, Victor Hugo Oidor-Chan, Julieta Anabell Díaz-Juárez, Raúl Martínez-Memíje, Vicente Castrejón-Téllez and Juan Carlos Torres-Narváez
Molecules 2026, 31(13), 2212; https://doi.org/10.3390/molecules31132212 - 23 Jun 2026
Viewed by 592
Abstract
Background: Systemic arterial hypertension (SAH) induced by Nω-nitro-L-arginine methyl ester (L-NAME) is a well-established model characterized by nitric oxide (NO) synthase inhibition and vascular dysfunction. The transient receptor potential vanilloid 1 (TRPV1) regulates Ca2+ flux and may contribute to mitochondrial [...] Read more.
Background: Systemic arterial hypertension (SAH) induced by Nω-nitro-L-arginine methyl ester (L-NAME) is a well-established model characterized by nitric oxide (NO) synthase inhibition and vascular dysfunction. The transient receptor potential vanilloid 1 (TRPV1) regulates Ca2+ flux and may contribute to mitochondrial homeostasis. We hypothesized that TRPV1 activation modulates mitochondria function and attenuates cardiac damage during SAH. Methods: Hypertension was induced in Wistar rats by administration of L-NAME (200 mg/L) for 40 days. During the last four days, hypertensive animals received capsaicin (5 mg/kg/day), capsazepine (6 mg/kg/day), or their combination. Cardiac function was evaluated in isolated hearts using the Langendorff perfusion system. Myocardial tissue viability was assessed by triphenyltetrazolium chloride (TTC) staining, and mitochondrial function was evaluated by measuring respiratory control and apoptosis-related proteins. Results: Capsaicin treatment was associated with significant cardioprotective effects in hypertensive rats. Although the findings are consistent with a role of TRPV1 activation in mediating these effects, the partial protection observed with capsazepine suggests that TRPV1-independent mechanisms may also contribute. Conclusions: TRPV1 activation contributes to cardioprotection in SAH, likely through preservation of mitochondrial function and redox balance. However, additional mechanisms beyond TRPV1 modulation may also participate in the observed protective effects. Further studies—including direct assessment of mitochondrial Ca2+ flux and the use of more selective or genetic approaches—are currently underway to clarify the underlying mechanisms. Full article
Show Figures

Figure 1

Back to TopTop